m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00680
|
[1], [2], [3] | |||
: m6A sites
Indirect
Enhancement
RNA modification
ITGA6
ITGA6
FTO
Demethylation
: modification sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 3 (METTL3) | WRITER | |||
| m6A Target | microRNA-92a | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> N6,2'-O-dimethyladenosine (m6Am) | ||||
| Epigenetic Regulator | Fat mass and obesity-associated protein (FTO) | ERASER | View Details | ||
| Regulated Target | Integrin alpha-6 (ITGA6) | View Details | |||
| Crosstalk Relationship | m6A → m6Am | Enhancement | |||
| Crosstalk Mechanism | m6A modification indirectly impacts RNA modification through downstream signaling pathways | ||||
| Crosstalk Summary | METTL3 interacts with microRNA-92a, decreasing its m6A level and promoting its physical interaction with Integrin alpha-6 (ITGA6), which was regulated by FTO-mediated m6Am modification. | ||||
In-vitro Model |
HT-1376 | Bladder carcinoma | Homo sapiens | CVCL_1292 | |
| HT-1197 | Recurrent bladder carcinoma | Homo sapiens | CVCL_1291 | ||
| MKN45 | Gastric adenocarcinoma | Homo sapiens | CVCL_0434 | ||
References
: m6A sites
: modification sites